CI
JNCE

Conning Inc’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Conning Inc’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-125,960
Closed -$1.61M – 602
2017
Q4 		$1.61M Hold
125,960
– – 0.05% 211
2017
Q3 		$1.96M Buy
125,960
+33,350
+36% +$519K 0.07% 195
2017
Q2 		$1.3M Buy
+92,610
New +$1.3M 0.05% 239